Cite
HARVARD Citation
Gandra, S. et al. (2016). Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States. Clinical cardiology. 39 (6), pp. 313-320. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gandra, S. et al. (2016). Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States. Clinical cardiology. 39 (6), pp. 313-320. [Online].